The Tolerability and Pharmacokinetics of Multiple Doses of SPH3127 in Chinese Healthy People
Clinical trial NCT03255993 · COMPLETED
Trial details
- NCT number
- NCT03255993
- Sponsor
- Shanghai Pharmaceuticals Holding Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-23
- Primary completion
- 2018-09-20
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.